DEMG — Deltex Medical Cashflow Statement
0.000.00%
Last trade - 00:00- £2.56m
- £3.63m
- £1.78m
Annual cashflow statement for Deltex Medical, fiscal year end - December 31st, GBP millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -0.21 | -0.794 | -0.978 | -1.15 | -1.28 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 0.255 | 0.256 | 0.209 | 0.288 | 0.306 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.331 | 0.327 | 0.364 | 0.124 | -0.352 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 0.609 | -0.068 | -0.291 | -0.606 | -1.2 |
| Capital Expenditures | -0.26 | -0.171 | -0.644 | -0.744 | -0.37 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 0.059 | 0 | — | — | — |
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.201 | -0.171 | -0.644 | -0.744 | -0.37 |
| Financing Cash Flow Items | 0 | -0.003 | 0 | -0.115 | -0.193 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -0.067 | 0.19 | 0.502 | 1.41 | 1.79 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.328 | -0.055 | -0.44 | 0.058 | 0.234 |